Daconib 45 Mg (Dacomitinib) – 30 Tablets

Daconib 45 Mg (Dacomitinib) marks a significant milestone in the realm of advanced lung cancer therapy. The active ingredient, Dacomitinib, is a potent and irreversible pan-human epidermal growth factor receptor (EGFR) inhibitor, offering targeted treatment for individuals with EGFR-mutated non-small cell lung cancer (NSCLC).

Daconib 45 mg operates by specifically and irreversibly inhibiting EGFR, blocking the signaling pathways responsible for the uncontrolled growth of cancer cells. This targeted approach is particularly effective in EGFR-mutated NSCLC.

Daconib (Dacomitinib) is primarily employed for the treatment of:

• EGFR-Mutated Non-Small Cell Lung Cancer (NSCLC): Prescribed for individuals with advanced NSCLC harboring EGFR mutations, Daconib offers a targeted therapeutic option.

Product Feature:

You will have the ability to order easily and pay the best price if you use Unit Pharmacy Website for buying Daconib 45 Mg (Dacomitinib) medicine.